Boston Scientific and Avivagen are competing in the medical device market, with analysts using MarketBeat for ratings.
1 report, 1 independent
Updated Jun 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Boston Scientific and Avivagen are competing in the medical device market, with analysts using MarketBeat for ratings.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- MarketBeat highlighted Boston Scientific as a stock to watch on July 29, 2026.Sub-event
Boston Scientific and Avivagen compete in the medical device market.1 source
Keep exploring
The entities involved
-
Boston Scientific
worldwide developer, manufacturer and marketer of medical devices
-
MarketBeat
American personal finance blog
Related events
- MarketBeat uses for analyst ratings and competes in the medical device market, involving Teleflex and Vasamed.
- Pro-Dex, Inc. is competing in the medical-surgical products market and was rated and analyzed by MarketBeat on September 1, 2026.
- Stryker Corporation, Boston Scientific, and Medtronic plc are competing in the medical device market.
- MarketBeat is providing analyst ratings and tracking the competitive landscape between healthcare companies Pfizer and Lyra Therapeutics.
- Rapid Micro Biosystems and Thermo Fisher Scientific are competing in the life sciences/healthcare market, with MarketBeat providing analyst ratings and coverage.